The CAR T Cell Therapy Market is estimated to be valued at US$2.26 billion in 2022 and is expected to exhibit a CAGR of 20.9% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:CAR T cell therapy is a personalized immunotherapy that utilizes genetically modified T cells to target and kill cancer cells. This therapy has shown...